User profiles for JA Capriotti

Joseph Capriotti

Verified email at velocebiopharma.com
Cited by 1431

[HTML][HTML] Dimethyl sulfoxide: history, chemistry, and clinical utility in dermatology

K Capriotti, JA Capriotti - The Journal of clinical and aesthetic …, 2012 - ncbi.nlm.nih.gov
Dimethyl sulfoxide is a colorless liquid derived as a by-product from wood pulp in the production
of paper. This colorless liquid found immediate application as a polar, aprotic solvent …

Efficacy of povidone-iodine nasal and oral antiseptic preparations against severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2)

…, JB Westover, SM Brown, JA Capriotti - Ear, Nose & Throat …, 2021 - journals.sagepub.com
… Dr Capriotti is the executive director of Veloce BioPharma and reported a patent to multiple
related … Capriotti and Jesse S Pelletier are executive board members at Veloce BioPharma. …

[HTML][HTML] Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis

…, JA Capriotti, M Kumar, JA Hobden… - … & visual science, 2011 - iovs.arvojournals.org
Purpose.: To determine the efficacy of a new formulation of topical dexamethasone 0.1%/povidone-iodine
0.4%(FST-100) in reducing clinical symptoms and infectious viral titers in a …

Normal ocular flora in healthy eyes from a rural population in Sierra Leone

JA Capriotti, JS Pelletier, M Shah, DM Caivano… - International …, 2009 - Springer
Purpose To identify the normal conjunctival flora in a rural population in Sierra Leone and
compare the normal ocular flora of a developing country with that of the developed world. …

In vitro efficacy of a povidone-iodine nasal antiseptic for rapid inactivation of SARS-CoV-2

S Frank, SM Brown, JA Capriotti… - … –Head & Neck …, 2020 - jamanetwork.com
… Dr Capriotti is the executive director of Veloce BioPharma and reported a patent to multiple
related drugs issued and licensed by Veloce BioPharma. Dr Pelletier is a consultant for …

A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis

…, S Braverman, CM Samson, B Liang, JA Capriotti - Advances in …, 2009 - Springer
Introduction The objective of this pilot study was to determine the preliminary efficacy of a
novel ophthalmic suspension containing povidone-iodine 0.4% and dexamethasone 0.1% in …

The risk of nail changes with taxane chemotherapy: a systematic review of the literature and meta‐analysis

K Capriotti, JA Capriotti, S Lessin, S Wu… - British Journal of …, 2015 - academic.oup.com
DEAR EDITOR, Taxanes are an established and powerful class of cytotoxic chemotherapeutic
agents that exhibit a wide spectrum of activity against solid tumours including breast, …

[HTML][HTML] Topical iodophor preparations: chemistry, microbiology, and clinical utility

K Capriotti, JA Capriotti - Dermatology online journal, 2012 - escholarship.org
Iodophor preparations are commonly used in all medical specialties for antisepsis of the
skin prior to injections, invasive procedures, and surgery. Povidone-iodine has some very …

In vitro efficacy of a povidone–iodine 0.4% and dexamethasone 0.1% suspension against ocular pathogens

…, D Miller, B Liang, JA Capriotti - Journal of Cataract & …, 2011 - journals.lww.com
… Liang and Capriotti have a proprietary interest in the antiinfective product. … Speaker MG,
Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. …

New lithium porphyrin derivatives: synthesis of Li2 (P)(Et2O) 2 (P= TTP, TBPP) and solution structure of Li2 (TTP)(Et2O) 2 by 7Li and 15N NMR

H Brand, JA Capriotti, J Arnold - Inorganic Chemistry, 1994 - ACS Publications
Capriotti, and John Arnold* … JAthanks the Alfred P. Sloan Foundation for the award of a
research fellowship. …